Can a simple drug stop dangerous bleeding in kidney patients during surgery?
NCT ID NCT06337838
First seen Mar 29, 2026 · Last updated Jun 12, 2026 · Updated 12 times
Summary
This study tests whether giving two common drugs, tranexamic acid and desmopressin, before surgery can reduce bleeding in patients with chronic kidney disease or acute kidney injury. About 100 adults having noncardiac surgery will be randomly assigned to receive one or both drugs or a placebo. The goal is to see if these drugs are safe and effective at preventing serious bleeding complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de L'Universite de Montreal (CHUM)
ACTIVE_NOT_RECRUITINGMontreal, Quebec, H2X 0A9, Canada
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5A5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
McGill University University Health Centre
RECRUITINGMontreal, Quebec, H3H 2R9, Canada
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.